October 01, 2026 article Open access The IFN-γ response cycle: decoupling tumor killing from evolutionary selection in cancer immunotherapy Frontiers in Immunology DOI: 10.3389/fimmu.2026.1954319 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 0 stored of 0 References 4 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access IFN-γ signature enables selection of neoadjuvant treatment in patients with stage III melanoma 2023 The Journal of Experimental Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 3 patents 80 citations Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma 2024 Journal for ImmunoTherapy of Cancer article Medicine Cutaneous Melanoma Detection and Management Open access 25 citations Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma 2024 JCI Insight article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent 25 citations Abstract 2803: Ex vivo micro-tumor testing platform to characterize and predict patient-specific immunotherapy drug responses 2026 Cancer Research conference-abstract Medicine Cancer Immunotherapy and Biomarkers 1 citations 4 results